Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table

Authors :: Idrus, Amirah Al
Source :: Fiercebiotech.com. July 22, 2021
Publication Year :: 2021
Abstract: Byline: Amirah Al Idrus Pfizer is doubling down on Arvinas. Three years after the duo inked a discovery and development deal, they're adding commercialization to the mix. Pfizer is forking [...]

Subjects :: Pfizer Inc.
Drug approval
Pharmaceutical industry
Biotechnology industry

Tools